TAK — Takeda Pharmaceutical Co Ltd ADR

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

Trend Edge Setup Score

Trend Edge rates TAK Bullish with a Setup Score of 0, net conviction 40, actionability 0. How the Setup Score works →

Total Setup Score0
Directional BiasBullish
Net Conviction40
Actionability0 (extended)

Key signals behind this score

About Takeda Pharmaceutical Co Ltd ADR

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma-derived therapies, oncology, vaccines, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab/Vocinti, EOHILIA, Takhzyro, Advate, Elaprase, Replagal, Vpriv, Adynovate/Adyno… Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$18.23
Market Cap$57.90B
Float3.16B
Shares Outstanding3.19B
P/E (Forward)11.33
Price/Sales (TTM)0.01
vs. Analyst Target+20.7% to analyst PT
Profit Margin-3.54%
Operating Margin (TTM)16.45%
Revenue (TTM)$4.62T
Earnings Growth (YoY)-9.80%
Dividend Rate0.6%
Analyst Target Price$22.00 (4 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2021 $3.20T $376.00B $2.20T $983.72B
2022 $3.57T $230.06B $2.46T $1.18T
2023 $4.03T $317.02B $2.78T $1.28T
2024 $4.26T $144.07B $2.83T $1.14T
2025 $4.58T $107.93B $3.00T $1.21T
2026 $4.78T $203.33B $2.44T $1.42T

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Sep 2025 $1.11T -$11.80B
Dec 2025 $1.21T $105.51B
Mar 2026 $1.11T -$24.77B
Jun 2026 $1.22T $113.20B

Ownership & Float

Insider Ownership0.1%
Institutional Ownership3.3%
Short Float0.1%
% of All Funds Holding4.25%
Number of Funds Holding374

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$17.22Near-term / short-term trend
Weekly40-Week SMA$16.82Medium-term trend
Weekly80-Week SMA$15.73Cyclical trend (business cycle)
Weekly200-Week SMA$15.06Secular trend (multi-year)
Monthly10-Month SMA$16.85Near-term monthly trend
Monthly20-Month SMA$15.69Medium-term monthly trend
Monthly40-Month SMA$14.99Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$16.00 support 1.33x 0 months ago
$15.70 support 1.10x 6 months ago
$13.40 support 1.08x 8 months ago
$13.00 support 1.38x 24 months ago

Historical Earnings Reactions (65 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap -0.11% 0.12% 52.31% 3.91% -6.77%
1 Day -0.01% 0.00% 49.23% 3.84% -4.73%
1 Week 0.12% -0.07% 47.69% 11.69% -9.39%
2 Weeks 0.78% 0.65% 53.85% 13.36% -8.90%
1 Month 0.48% 0.08% 51.56% 14.98% -12.36%

Next earnings: October 18, 2026 (52 days away)

Seasonality & Day-of-Week Patterns

Monthly Seasonality

MonthAvg ReturnWin RateSamples
Jan4.4%68.8%16
Feb1.6%64.7%17
Mar-1.8%35.3%17
Apr-1.0%52.9%17
May-3.0%29.4%17
Jun0.6%47.1%17
Jul1.7%64.7%17
Aug0.7%56.3%16
Sep-1.2%31.3%16
Oct-2.0%50.0%16
Nov0.2%37.5%16
Dec0.8%62.5%16

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday 0.04% 52.4% 783
Tuesday 0.01% 49.5% 860
Wednesday -0.00% 49.5% 858
Thursday -0.04% 49.7% 843
Friday 0.02% 51.3% 839

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 3.3%

Insider Transactions — Smart Summary

Total insider ownership: 0.1%

12-Month Insider Activity Summary

Total Filings17
Net Value-$11.3M
Net Shares Change-653,576
% of Float-0.0%
C-Suite Filings17
Clusters Detected1

Key Insiders

NameTitleNet ValueFilingsActivity
Plump Andrew Stewart President, R&D -$2.8M 1 1 sell
Greenway Nicola Deidre Petal Chief Human Resources Officer -$1.6M 3 3 sell
Kim Julie So-Young President and CEO -$1.5M 1 1 sell
Shannon Elaine Mary Pres., Global Supply & Quality -$782,766.137 2 2 sell
Furney Natalie Anne Marie Global General Counsel -$527,842.8 1 1 sell
Ricci Gabriele Chief Data & Tech. Officer -$429,004.8 1 1 sell
Pignagnoli Agosti Marcello Head, Strat. & Port. Dev -$392,564.7 1 1 sell

Transaction Clusters

PeriodFilingsInsidersNet ValueSeniority
2026-08-12 – 2026-08-21 17 13 -$11.3M 17 C-suite

Significant Filings

DateInsiderTitleNet ValuePrice After
2026-08-12 Plump Andrew Stewart President, R&D -$2.8M Transaction at $17.10, now +6.6%
2026-08-12 Kim Julie So-Young President and CEO -$1.5M Transaction at $17.10, now +6.6%
2026-08-19 Greenway Nicola Deidre Petal Chief Human Resources Officer -$235,118.422 Transaction at $18.11, now +0.6%
2026-08-12 Shannon Elaine Mary Pres., Global Supply & Quality -$357,370.65 Transaction at $17.55, now +3.9%
2026-08-12 Shannon Elaine Mary Pres., Global Supply & Quality -$425,395.487 Transaction at $17.48, now +4.3%
2026-08-12 Ricci Gabriele Chief Data & Tech. Officer -$429,004.8 Transaction at $17.10, now +6.6%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Takeda Pharmaceutical Co Ltd ADR (TAK) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for TAK on Trend Edge →